FC
ABT icon

Fairscale Capital’s Abbott ABT Stock Holding History

Fairscale Capital’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
1,399
-525
-27% -$47.9K 0.08% 132
2026
Q1 		$198K Hold
1,924
– – 0.14% 101
2025
Q4 		$241K Hold
1,924
– – 0.16% 82
2025
Q3 		$258K Hold
1,924
– – 0.18% 81
2025
Q2 		$243K Buy
1,924
+386
+25% +$50.9K 0.18% 80
2025
Q1 		$204K Buy
1,538
+228
+17% +$29K 0.18% 80
2024
Q4 		$148K Hold
1,310
– – 0.13% 90
2024
Q3 		$149K Hold
1,310
– – 0.13% 92
2024
Q2 		$135K Buy
+1,310
New +$139K 0.12% 99

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fairscale Capital's ABT Position: Q2 2026 in Review

Fairscale Capital reduced its Abbott (ABT) stake by 27% in Q2 2026, selling an estimated $47.9K and leaving 1,399 shares worth $127K. The position accounts for 0.08% of the portfolio, ranked #132.

Fairscale Capital first reported a position in ABT in Q2 2024 and has held it in 9 quarters since. The position peaked at $258K in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Fairscale Capital held 1,399 shares of Abbott worth $127K as of Q2 2026.
  • Fairscale Capital sold 525 Abbott shares in Q2 2026, an estimated $47.9K.
  • Abbott made up 0.08% of Fairscale Capital's portfolio in Q2 2026, its #132 holding.
  • Fairscale Capital first reported a position in Abbott in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Abbott position peaked at $258K in Q3 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.